Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis

Ripu Hundal,1 Stephan Kowalyk,2 Amanda Wakim,3 Carla Nikkel,4 John H Sink II,4 Melissa Doyle5 1First State Endocrinology, Newark, DE, USA; 2Endocrinology Specialists PC, Greensburg, PA, USA; 3Center of Endocrinology, Wheeling Hospital, Wheeling, WV, USA; 4Medical Affairs, Zealand Pharma, Boston, MA,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hundal R, Kowalyk S, Wakim A, Nikkel C, Sink II JH, Doyle M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	basal-bolus insulin insulin delivery device patch type 2 diabetes v-go Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/bb1bbf8f0b9d4a429bec60992ef3084d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bb1bbf8f0b9d4a429bec60992ef3084d
record_format	dspace
spelling	oai:doaj.org-article:bb1bbf8f0b9d4a429bec60992ef3084d2021-12-02T03:50:36ZMulticenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis1179-1470https://doaj.org/article/bb1bbf8f0b9d4a429bec60992ef3084d2020-09-01T00:00:00Zhttps://www.dovepress.com/multicenter-real-world-assessment-of-the-effectiveness-of-v-go-wearabl-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Ripu Hundal,1 Stephan Kowalyk,2 Amanda Wakim,3 Carla Nikkel,4 John H Sink II,4 Melissa Doyle5 1First State Endocrinology, Newark, DE, USA; 2Endocrinology Specialists PC, Greensburg, PA, USA; 3Center of Endocrinology, Wheeling Hospital, Wheeling, WV, USA; 4Medical Affairs, Zealand Pharma, Boston, MA, USA; 5Progressive Diabetes Care, PLLC, Erwin, NC, USACorrespondence: Carla NikkelMedical Affairs, Zealand Pharma, 34 Farnsworth St, Floor 4, Boston, MA 02210, USATel +1 405-509-0401Fax +1 405-330-4040Email cnikkel@zealandpharma.comPurpose: Patch-like wearable insulin delivery devices are gaining acceptance as a treatment modality for insulin delivery in patients with diabetes. These devices aim to simplify and optimize insulin delivery while reducing barriers associated with a basal-bolus insulin regimen. As clinicians aim to learn more about this method of insulin delivery, real-world evidence can provide insight for patient identification and treatment guidance. This study was performed to evaluate the change in glycemic control (A1C) and insulin total daily dose (TDD) after switching to V-Go wearable insulin delivery device in a type 2 diabetes population with suboptimal control using conventional insulin delivery regimens.Patients and Methods: Electronic health records were queried to identify patients meeting inclusion criteria. Study objectives evaluated change in A1C and insulin TDD compared to baseline. A total of 283 patients were enrolled across 9 diabetes specialty sites.Results: A1C significantly decreased from baseline at 3 months (− 1.01% ± 0.09; P=0.0001) and 7 months (− 1.04% ± 0.10; P< 0.0001) after switching to V-Go. TDD of insulin significantly decreased at 3 months (− 17 ± 3 U/day; P< 0.0001) and 7 months (− 14 ± 3 U/day; P< 0.0001). Stratifying by prescribed baseline insulin regimen (basal-bolus, basal only or premix) or diabetes duration (< 5 years to > 20 years) demonstrated significant glycemic improvements from baseline with V-Go regardless of baseline regimen or duration of diabetes. After 7 months of V-Go use, the percent of patients considered high risk (A1C > 9.0%) was reduced by nearly half (46% to 24%), and 52% of patients overall achieved an A1C < 8%.Conclusion: This study represents the largest real-world study of the effectiveness of V-Go in patients with type 2 diabetes. Significant improvements in glycemic control with a reduction in insulin utilization were achieved across varying baseline insulin regimens and regardless of diabetes duration supporting the clinical benefits of this patch-like wearable insulin delivery device.Keywords: basal-bolus, insulin, insulin delivery device, patch, type 2 diabetes, V-GoHundal RKowalyk SWakim ANikkel CSink II JHDoyle MDove Medical Pressarticlebasal-bolusinsulininsulin delivery devicepatchtype 2 diabetesv-goMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 13, Pp 283-291 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	basal-bolus insulin insulin delivery device patch type 2 diabetes v-go Medical technology R855-855.5
spellingShingle	basal-bolus insulin insulin delivery device patch type 2 diabetes v-go Medical technology R855-855.5 Hundal R Kowalyk S Wakim A Nikkel C Sink II JH Doyle M Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
description	Ripu Hundal,1 Stephan Kowalyk,2 Amanda Wakim,3 Carla Nikkel,4 John H Sink II,4 Melissa Doyle5 1First State Endocrinology, Newark, DE, USA; 2Endocrinology Specialists PC, Greensburg, PA, USA; 3Center of Endocrinology, Wheeling Hospital, Wheeling, WV, USA; 4Medical Affairs, Zealand Pharma, Boston, MA, USA; 5Progressive Diabetes Care, PLLC, Erwin, NC, USACorrespondence: Carla NikkelMedical Affairs, Zealand Pharma, 34 Farnsworth St, Floor 4, Boston, MA 02210, USATel +1 405-509-0401Fax +1 405-330-4040Email cnikkel@zealandpharma.comPurpose: Patch-like wearable insulin delivery devices are gaining acceptance as a treatment modality for insulin delivery in patients with diabetes. These devices aim to simplify and optimize insulin delivery while reducing barriers associated with a basal-bolus insulin regimen. As clinicians aim to learn more about this method of insulin delivery, real-world evidence can provide insight for patient identification and treatment guidance. This study was performed to evaluate the change in glycemic control (A1C) and insulin total daily dose (TDD) after switching to V-Go wearable insulin delivery device in a type 2 diabetes population with suboptimal control using conventional insulin delivery regimens.Patients and Methods: Electronic health records were queried to identify patients meeting inclusion criteria. Study objectives evaluated change in A1C and insulin TDD compared to baseline. A total of 283 patients were enrolled across 9 diabetes specialty sites.Results: A1C significantly decreased from baseline at 3 months (− 1.01% ± 0.09; P=0.0001) and 7 months (− 1.04% ± 0.10; P< 0.0001) after switching to V-Go. TDD of insulin significantly decreased at 3 months (− 17 ± 3 U/day; P< 0.0001) and 7 months (− 14 ± 3 U/day; P< 0.0001). Stratifying by prescribed baseline insulin regimen (basal-bolus, basal only or premix) or diabetes duration (< 5 years to > 20 years) demonstrated significant glycemic improvements from baseline with V-Go regardless of baseline regimen or duration of diabetes. After 7 months of V-Go use, the percent of patients considered high risk (A1C > 9.0%) was reduced by nearly half (46% to 24%), and 52% of patients overall achieved an A1C < 8%.Conclusion: This study represents the largest real-world study of the effectiveness of V-Go in patients with type 2 diabetes. Significant improvements in glycemic control with a reduction in insulin utilization were achieved across varying baseline insulin regimens and regardless of diabetes duration supporting the clinical benefits of this patch-like wearable insulin delivery device.Keywords: basal-bolus, insulin, insulin delivery device, patch, type 2 diabetes, V-Go
format	article
author	Hundal R Kowalyk S Wakim A Nikkel C Sink II JH Doyle M
author_facet	Hundal R Kowalyk S Wakim A Nikkel C Sink II JH Doyle M
author_sort	Hundal R
title	Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
title_short	Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
title_full	Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
title_fullStr	Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
title_full_unstemmed	Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
title_sort	multicenter real-world assessment of the effectiveness of v-go wearable insulin delivery device in adult patients with type 2 diabetes (enable study): a retrospective analysis
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/bb1bbf8f0b9d4a429bec60992ef3084d
work_keys_str_mv	AT hundalr multicenterrealworldassessmentoftheeffectivenessofvgowearableinsulindeliverydeviceinadultpatientswithtype2diabetesenablestudyaretrospectiveanalysis AT kowalyks multicenterrealworldassessmentoftheeffectivenessofvgowearableinsulindeliverydeviceinadultpatientswithtype2diabetesenablestudyaretrospectiveanalysis AT wakima multicenterrealworldassessmentoftheeffectivenessofvgowearableinsulindeliverydeviceinadultpatientswithtype2diabetesenablestudyaretrospectiveanalysis AT nikkelc multicenterrealworldassessmentoftheeffectivenessofvgowearableinsulindeliverydeviceinadultpatientswithtype2diabetesenablestudyaretrospectiveanalysis AT sinkiijh multicenterrealworldassessmentoftheeffectivenessofvgowearableinsulindeliverydeviceinadultpatientswithtype2diabetesenablestudyaretrospectiveanalysis AT doylem multicenterrealworldassessmentoftheeffectivenessofvgowearableinsulindeliverydeviceinadultpatientswithtype2diabetesenablestudyaretrospectiveanalysis
_version_	1718401614132281344

Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis

Ejemplares similares